00226-8/asset/fd74d5b9-b94f-420a-ba3e-9f0baf1be2f1/main.assets/gr2_lrg.jpg)
semaglutide weight loss trial sign up Once-weekly 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b Effect of Continued Weekly Subcutaneous
Description
A novel glucagon-like peptide-1/glucagon receptor dual agonist exhibits weight-lowering and diabetes-protective effects
The company's published study demonstrates outcomes within their protocol, but doesn't isolate the individualized dosing variable from other program elements like holistic consultations, coaching, and community support
Instead, the Wegovy pill is introduced slowly so your body has time to adjust, and side effects, like nausea, are less likely
Sjbjerg A, Poulsen PL, Kramer S, Richelsen B
